IL-15 participates in the respiratory innate immune response to influenza virus infection

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Verbist, Katherine C ^a   Rose, David L ^a   Cole, Charles J ^a   Field, Mary B ^a   Klonowski, Kimberly D ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; IMMUNOREGULATION; INFLUENZA; INNATE IMMUNITY; LYMPHOCYTE DEPLETION; MOUSE; NATURAL KILLER CELL; NONHUMAN; RESPIRATORY SYSTEM; VIRUS INHIBITION; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CELL MOTION; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; LUNG LAVAGE; ORTHOMYXOVIRUS INFECTION; VIROLOGY;

MURINAE; ORTHOMYXOVIRIDAE;

ANIMALS; BRONCHOALVEOLAR LAVAGE; CELL MOVEMENT; FLOW CYTOMETRY; IMMUNITY, INNATE; INTERLEUKIN-15; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; RESPIRATORY SYSTEM;

EID: 84862094912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037539     Document Type: Article

References (54)

1. Fouchier RA, Rimmelzwaan GF, Kuiken T, Osterhaus AD, (2005) Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses. Curr Opin Infect Dis 18: 141-146.
2. Kilbourne ED, (2004) Influenza pandemics: can we prepare for the unpredictable? Viral Immunol 17: 350-357.
3. Crowe JE Jr, (1999) Host responses to respiratory virus infection and immunization. Curr Top Microbiol Immunol 236: 191-214.
4. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, et al. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-117.
5. Allan W, Tabi Z, Cleary A, Doherty PC, (1990) Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J Immunol 144: 3980-3986.
6. Woodland DL, (2003) Cell-mediated immunity to respiratory virus infections. Curr Opin Immunol 15: 430-435.
7. Kos FJ, Engleman EG, (1996) Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol 173: 1-6.
8. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, (2008) Functions of natural killer cells. Nat Immunol 9: 503-510.
9. Stein-Streilein J, Guffee J, (1986) In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection. J Immunol 136: 1435-1441.
10. Denney L, Aitken C, Li CK, Wilson-Davies E, Kok WL, et al. (2010) Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PLoS One 5: e10675.
11. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, et al. (2001) Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 31: 2680-2689.
12. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
13. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
14. Kos FJ, Engleman EG, (1996) Immune regulation: a critical link between NK cells and CTLs. Immunol Today 17: 174-176.
15. Groom JR, Luster AD, (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89: 207-215.
16. Azimi N, Shiramizu KM, Tagaya Y, Mariner J, Waldmann TA, (2000) Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J Virol 74: 7338-7348.
17. Yamaji K, Nabeshima S, Murata M, Chong Y, Furusyo N, et al. (2006) Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment. Cancer Immunol Immunother 55: 394-403.
18. Mattei F, Schiavoni G, Belardelli F, Tough DF, (2001) IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 167: 1179-1187.
19. Verbist KC, Cole CJ, Field MB, Klonowski KD, (2011) A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection. J Immunol 186: 174-182.
20. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, et al. (2000) Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191: 771-780.
21. Castillo EF, Stonier SW, Frasca L, Schluns KS, (2009) Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 trans-presentation. J Immunol 183: 4948-4956.
22. Walzer T, Dalod M, Vivier E, Zitvogel L, (2005) Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opin Biol Ther 5 (Suppl 1): S49-59.
23. Stoklasek TA, Schluns KS, Lefrancois L, (2006) Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J Immunol 177: 6072-6080.
24. Elpek KG, Rubinstein MP, Bellemare-Pelletier A, Goldrath AW, Turley SJ, (2010) Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes. Proc Natl Acad Sci U S A 107: 21647-21652.
25. Allavena P, Giardina G, Bianchi G, Mantovani A, (1997) IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J Leukoc Biol 61: 729-735.
26. Matrosovich M, Matrosovich T, Garten W, Klenk HD, (2006) New low-viscosity overlay medium for viral plaque assays. Virol J 3: 63.
27. McGill J, Van Rooijen N, Legge KL, (2010) IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J Exp Med 207: 521-534.
28. Budagian V, Bulanova E, Paus R, Bulfone-Paus S, (2006) IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 17: 259-280.
29. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, et al. (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206: 25-34.
30. Castillo EF, Acero LF, Stonier SW, Zhou D, Schluns KS, (2010) Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation. Blood 116: 2494-2503.
31. Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, et al. (2005) Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 105: 721-727.
32. Dubois S, Mariner J, Waldmann TA, Tagaya Y, (2002) IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537-547.
33. Chae DW, Nosaka Y, Strom TB, Maslinski W, (1996) Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression. J Immunol 157: 2813-2819.
34. Hogan RJ, Usherwood EJ, Zhong W, Roberts AA, Dutton RW, et al. (2001) Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 166: 1813-1822.
35. Sun JC, Lanier LL, (2011) NK cell development, homeostasis and function: parallels with CD8 T cells. Nat Rev Immunol 11: 645-657.
36. Kitaya K, Yamaguchi T, Honjo H, (2005) Central role of interleukin-15 in postovulatory recruitment of peripheral blood CD16(-) natural killer cells into human endometrium. J Clin Endocrinol Metab 90: 2932-2940.
37. Shen CH, Ge Q, Talay O, Eisen HN, Garcia-Sastre A, et al. (2008) Loss of IL-7R and IL-15R expression is associated with disappearance of memory T cells in respiratory tract following influenza infection. J Immunol 180: 171-178.
38. Kulkarni RR, Haeryfar SM, Sharif S, (2010) The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity? J Leukoc Biol 88: 635-643.
39. Ho LP, Denney L, Luhn K, Teoh D, Clelland C, et al. (2008) Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur J Immunol 38: 1913-1922.
40. Benton KA, Misplon JA, Lo CY, Brutkiewicz RR, Prasad SA, et al. (2001) Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J Immunol 166: 7437-7445.
41. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, et al. (1994) Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264: 965-968.
42. Ahmad R, Ennaciri J, Cordeiro P, El Bassam S, Menezes J, (2007) Herpes simplex virus-1 up-regulates IL-15 gene expression in monocytic cells through the activation of protein tyrosine kinase and PKC zeta/lambda signaling pathways. J Mol Biol 367: 25-35.
43. Doherty TM, Seder RA, Sher A, (1996) Induction and regulation of IL-15 expression in murine macrophages. J Immunol 156: 735-741.
44. Caufour P, Le Grand R, Cheret A, Neildez O, Thiebot H, et al. (2001) Longitudinal analysis of CD8(+) T-cell phenotype and IL-7, IL-15 and IL-16 mRNA expression in different tissues during primary simian immunodeficiency virus infection. Microbes Infect 3: 181-191.
45. Hocke AC, Hartmann IK, Eitel J, Optiz B, Scharf S, et al. (2008) Subcellular expression pattern and role of IL-15 in pneumococci induced lung epithelial apoptosis. Histochem Cell Biol 130: 165-176.
46. Muro S, Taha R, Tsicopoulos A, Olivenstein R, Tonnel AB, et al. (2001) Expression of IL-15 in inflammatory pulmonary diseases. J Allergy Clin Immunol 108: 970-975.
47. Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, et al. (1997) Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol 27: 1049-1054.
48. Onu A, Pohl T, Krause H, Bulfone-Paus S, (1997) Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J Immunol 158: 255-262.
49. Koka R, Burkett PR, Chien M, Chai S, Chan F, et al. (2003) Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 197: 977-984.
50. Assarsson E, Kambayashi T, Sandberg JK, Hong S, Taniguchi M, et al. (2000) CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J Immunol 165: 3673-3679.
51. Morandi B, Mortara L, Carrega P, Cantoni C, Costa G, et al. (2009) NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs. Int Immunol 21: 599-606.
52. Fehniger TA, Shah MH, Turner MJ, VanDeusen JB, Whitman SP, et al. (1999) Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162: 4511-4520.
53. Perera LP, Goldman CK, Waldmann TA, (1999) IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J Immunol 162: 2606-2612.
54. Barlic J, McDermott DH, Merrell MN, Gonzales J, Via LE, et al. (2004) Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms. J Biol Chem 279: 48520-48534.